CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as first...
Prof Suresh Ramalingam - Winship Cancer Institute of Emory University, Atlanta, ...
2 Jun 2020
ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer
Prof Benjamin Besse and Dr Alex Spira
2 Jun 2020
KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy f...
Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York City, USA
31 May 2020
Brigatinib for NSCLC, latest research and overcoming complications
Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA
29 May 2020
Sym015 shows superior specificity compared to TKIs for NSCLC
Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA
29 May 2020
ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer
Prof Roy Herbst - Yale Cancer Center, New Haven, USA
29 May 2020
Do immune checkpoint inhibitors work in EGFR mutant lung cancer?
Dr Edward Garon - UCLA Medical Center, Santa Monica, USA
22 May 2020
COVID-19: Risk of millions relapsing back to smoking
Dr Sudhanshu Patwardhan - Centre for Health Research and Education, Southampton,...
22 May 2020
TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patie...
Dr Heather Wakelee - Stanford University Medical Center, Stanford, USA
21 May 2020
COVID-19: Management of non-small cell lung cancer patients during the coronavir...
Dr Heather Wakelee - Stanford University, Stanford, USA
12 May 2020
Prostate cancer patients receiving androgen-deprivation therapies shown to be at...
Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerla...
7 May 2020
COVID-19: The situation in Florida and managing lung cancer patients
Dr. Luis Raez - Memorial Healthcare System, Florida, Miami
27 Apr 2020
